No, compounded tirzepatide is not the FDA-approved branded product, and it hasn't been through independent clinical testing
According to the drugs manufacturer, Zepbound is expected to be available to Americans by the end of the year for a list price of approximately $1,059, which Eli Lilly estimates is 20% less than rival semaglutide, otherwise known as Novo Nordisks Ozempic or Wegovy, which costs a staggering $1,300
Slimthetics Concentrates on Patient Education and Sound Weight Loss Methods
Our Tirzepatide Medical Weight Loss Program starts at just $36.95 per week and includes medication, supplies, and medical supervision
But there are specific considerations: Nausea may be more pronounced: Women report higher rates of GI side effects across GLP-1 trials, likely related to hormonal interactions with gut motility
Medicare and Medicaid may also offer coverage under specific conditions